{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:01:38Z","timestamp":1791302498807,"version":"4.1.0"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,12,15]]},"DOI":"10.1093\/hmg\/ddu366","type":"journal-article","created":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T01:19:30Z","timestamp":1405473570000},"page":"6458-6469","source":"Crossref","is-referenced-by-count":114,"title":["Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients"],"prefix":"10.1093","volume":"23","author":[{"given":"Yetrib","family":"Hathout","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramya L.","family":"Marathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree","family":"Rayavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haeri","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gordish-Dressman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebahattin","family":"Cirak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanneboyina","family":"Nagaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Partridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric P.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin'ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Mah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Henricson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"key\n\t\t\t\t20170522131328_DDU366C1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00393974","article-title":"Duchenne muscular dystrophy. A population study","volume":"35","author":"Danieli","year":"1977","journal-title":"Hum. Genet."},{"key":"key\n\t\t\t\t20170522131328_DDU366C2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2009","journal-title":"Lancet Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/archneur.1991.00530160047012","article-title":"Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group","volume":"48","author":"Griggs","year":"1991","journal-title":"Arch. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C4","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/adc.2007.118141","article-title":"Update on the management of Duchenne muscular dystrophy","volume":"93","author":"Manzur","year":"2008","journal-title":"Arch. Dis. Child."},{"key":"key\n\t\t\t\t20170522131328_DDU366C5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003725.pub3","article-title":"Glucocorticoid corticosteroids for Duchenne muscular dystrophy","author":"Manzur","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"key\n\t\t\t\t20170522131328_DDU366C6","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522131328_DDU366C7","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1001\/archneur.1987.00520200022012","article-title":"Prednisone treatment in Duchenne muscular dystrophy. Long-term Benefit","volume":"44","author":"DeSilva","year":"1987","journal-title":"Arch. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C8","first-page":"16","article-title":"The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy","volume":"31","author":"McAdam","year":"2012","journal-title":"Acta Myol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2012-303902","article-title":"Long-term benefits and adverse effects of intermittent versus daily glucocorticoids in boys with Duchenne muscular dystrophy","volume":"84","author":"Ricotti","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"Suppl. 1","key":"key\n\t\t\t\t20170522131328_DDU366C10","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/S0960-8966(02)00086-X","article-title":"Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy","volume":"12","author":"Aartsma-Rus","year":"2002","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522131328_DDU366C11","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1177\/0883073810371129","article-title":"Read-through strategies for suppression of nonsense mutations in Duchenne\/Becker muscular dystrophy: aminoglycosides and ataluren (PTC124)","volume":"25","author":"Finkel","year":"2010","journal-title":"J. Child. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/WCO.0b013e32832fd487","article-title":"Emerging genetic therapies to treat Duchenne muscular dystrophy","volume":"22","author":"Nelson","year":"2009","journal-title":"Curr. Opin. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C13","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/mt.2011.59","article-title":"Current status of pharmaceutical and genetic therapeutic approaches to treat DMD","volume":"19","author":"Pichavant","year":"2011","journal-title":"Mol. Ther."},{"key":"key\n\t\t\t\t20170522131328_DDU366C14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrg3460","article-title":"Therapy for Duchenne muscular dystrophy: renewed optimism from genetic approaches","volume":"14","author":"Fairclough","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"key\n\t\t\t\t20170522131328_DDU366C15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1517\/14712598.2014.866087","article-title":"New developments in the use of gene therapy to treat Duchenne muscular dystrophy","volume":"14","author":"Jarmin","year":"2014","journal-title":"Expert Opin. Biol. Ther."},{"key":"key\n\t\t\t\t20170522131328_DDU366C16","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/WCO.0b013e32834aa3f1","article-title":"Impending therapies for Duchenne muscular dystrophy","volume":"24","author":"Partridge","year":"2011","journal-title":"Curr. Opin. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C17","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(11)60756-3","article-title":"Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study","volume":"378","author":"Cirak","year":"2011","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522131328_DDU366C18","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa1011367","article-title":"Systemic administration of PRO051 in Duchenne's muscular dystrophy","volume":"364","author":"Goemans","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522131328_DDU366C19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchenne muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2012.04.078","article-title":"Gene therapy for muscular dystrophy: lessons learned and path forward","volume":"527","author":"Mendell","year":"2007","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20170522131328_DDU366C21","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/emmm.201302621","article-title":"VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects","volume":"5","author":"Heier","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"key\n\t\t\t\t20170522131328_DDU366C22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/mus.21544","article-title":"The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy","volume":"41","author":"McDonald","year":"2009","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522131328_DDU366C23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nmd.2009.06.368","article-title":"Reliability of the North Star Ambulatory Assessment in a multicentric setting","volume":"19","author":"Mazzone","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522131328_DDU366C24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pri.520","article-title":"Development of a functional assessment scale for ambulatory boys with Duchenne muscular dystrophy","volume":"17","author":"Scott","year":"2012","journal-title":"Physiother. Res. Int."},{"key":"key\n\t\t\t\t20170522131328_DDU366C25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1212\/WNL.0b013e318227b164","article-title":"Randomized, blinded trial of weekend vs daily prednisone in Duchenne muscular dystrophy","volume":"77","author":"Escolar","year":"2011","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522131328_DDU366C26","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1001\/archneur.1961.00450110050006","article-title":"Serum creatine phosphokinase. Activity in progressive muscular dystrophy and neuromuscular diseases","volume":"4","author":"Okinaka","year":"1961","journal-title":"Arch. Neurol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2217\/bmm.12.96","article-title":"Proteomic identification of biomarkers of skeletal muscle disorders","volume":"7","author":"Ohlendieck","year":"2013","journal-title":"Biomark. Med."},{"key":"key\n\t\t\t\t20170522131328_DDU366C28","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/emmm.201100133","article-title":"miRNAs as serum biomarkers for Duchenne muscular dystrophy","volume":"3","author":"Cacchiarelli","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"key\n\t\t\t\t20170522131328_DDU366C29","doi-asserted-by":"crossref","first-page":"e18388","DOI":"10.1371\/journal.pone.0018388","article-title":"Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy","volume":"6","author":"Mizuno","year":"2011","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522131328_DDU366C30","doi-asserted-by":"crossref","first-page":"e80263","DOI":"10.1371\/journal.pone.0080263","article-title":"Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy","volume":"8","author":"Zaharieva","year":"2013","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522131328_DDU366C31","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","article-title":"Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD)","volume":"21","author":"Nadarajah","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"key\n\t\t\t\t20170522131328_DDU366C32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/prca.201300072","article-title":"Fibronectin is a serum biomarker for Duchenne muscular dystrophy","volume":"8","author":"Cynthia Martin","year":"2014","journal-title":"Proteomics Clin. Appl."},{"key":"key\n\t\t\t\t20170522131328_DDU366C33","doi-asserted-by":"crossref","first-page":"e16039","DOI":"10.1371\/journal.pone.0016039","article-title":"Differential proteomic analysis of mammalian tissues using SILAM","volume":"6","author":"McClatchy","year":"2011","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522131328_DDU366C34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/mcp.M112.023127","article-title":"Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse","volume":"12","author":"Rayavarapu","year":"2013","journal-title":"Mol. Cell Proteomics"},{"key":"key\n\t\t\t\t20170522131328_DDU366C35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00688245","article-title":"Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy","volume":"77","author":"Cullen","year":"1988","journal-title":"Acta Neuropathol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0022-510X(81)90118-0","article-title":"Serum myoglobin in muscular dystrophy and carrier detection","volume":"51","author":"Nicholson","year":"1981","journal-title":"J. Neurol. Sci."},{"key":"key\n\t\t\t\t20170522131328_DDU366C37","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/clinchem\/37.1.36","article-title":"Carbonic anhydrase III in serum in muscular dystrophy and other neurological disorders: relationship with creatine kinase","volume":"37","author":"Ohta","year":"1991","journal-title":"Clin. Chem."},{"key":"key\n\t\t\t\t20170522131328_DDU366C38","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/mus.880171206","article-title":"Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse","volume":"17","author":"McArdle","year":"1994","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522131328_DDU366C39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.braindev.2007.01.009","article-title":"Cardiac troponin I for accurate evaluation of cardiac status in myopathic patients","volume":"29","author":"Matsumura","year":"2007","journal-title":"Brain Dev."},{"key":"key\n\t\t\t\t20170522131328_DDU366C40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/1097-4598(200103)24:3<399::AID-MUS1012>3.0.CO;2-B","article-title":"Coagulation and fibrinolysis disorder in muscular dystrophy","volume":"24","author":"Saito","year":"2001","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522131328_DDU366C41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/prca.200900116","article-title":"Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment","volume":"4","author":"Colussi","year":"2010","journal-title":"Proteomics Clin. Appl."},{"key":"key\n\t\t\t\t20170522131328_DDU366C42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00281-011-0290-8","article-title":"Fibrinogen as a key regulator of inflammation in disease","volume":"34","author":"Davalos","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C43","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/hmg\/dds012","article-title":"Amelioration of Duchenne muscular dystrophy in mdx mice by elimination of matrix-associated fibrin-driven inflammation coupled to the alphaMbeta2 leukocyte integrin receptor","volume":"21","author":"Vidal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522131328_DDU366C44","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jcb.20343","article-title":"Developmental regulation and cellular distribution of human cytosolic malate dehydrogenase (MDH1)","volume":"94","author":"Lo","year":"2005","journal-title":"J. Cell. Biochem."},{"key":"key\n\t\t\t\t20170522131328_DDU366C45","first-page":"257","article-title":"Malate dehydrogenases\u2014structure and function","volume":"21","author":"Minarik","year":"2002","journal-title":"Gen. Physiol. Biophys."},{"key":"key\n\t\t\t\t20170522131328_DDU366C46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1083\/jcb.151.6.1321","article-title":"Expression profiling in the muscular dystrophies: identification of novel aspects of molecular pathophysiology","volume":"151","author":"Chen","year":"2000","journal-title":"J. Cell. Biol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C47","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1096\/fj.11-190728","article-title":"Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload","volume":"26","author":"Frolova","year":"2012","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20170522131328_DDU366C48","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1480293","article-title":"The role of the novel adipocyte-derived hormone adiponectin in human disease","volume":"148","author":"Diez","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C49","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/mus.23879","article-title":"Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months","volume":"48","author":"Hollingsworth","year":"2013","journal-title":"Muscle Nerve"},{"key":"key\n\t\t\t\t20170522131328_DDU366C50","doi-asserted-by":"crossref","first-page":"e72121","DOI":"10.1371\/journal.pone.0072121","article-title":"Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice","volume":"8","author":"Hindi","year":"2013","journal-title":"PLoS ONE"},{"key":"key\n\t\t\t\t20170522131328_DDU366C51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/10409238.2013.770819","article-title":"Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade","volume":"48","author":"Vandooren","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C52","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/pmic.200700857","article-title":"Serum protein profiling in mice: identification of Factor XIIIa as a potential biomarker for muscular dystrophy","volume":"8","author":"Alagaratnam","year":"2008","journal-title":"Proteomics"},{"key":"key\n\t\t\t\t20170522131328_DDU366C53","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-510X(84)90084-4","article-title":"Plasma phosphoglycerate mutase as a marker of muscular dystrophy","volume":"65","author":"Chown","year":"1984","journal-title":"J. Neurol. Sci."},{"key":"key\n\t\t\t\t20170522131328_DDU366C54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1542\/peds.28.6.962","article-title":"Studies of enzymes in serum in muscular dystrophy. II. Diagnostic and prognostic significance in relatives of dystrophic persons","volume":"28","author":"Pearson","year":"1961","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20170522131328_DDU366C55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0065-2571(78)90069-9","article-title":"The substrate specificity and regulation of the protein phosphatases involved in the control of glycogen metabolism in mammalian skeletal muscle","volume":"16","author":"Cohen","year":"1977","journal-title":"Adv. Enzyme Regul."},{"key":"key\n\t\t\t\t20170522131328_DDU366C56","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3892\/ijmm.2013.1429","article-title":"Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy","volume":"32","author":"Carberry","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"key\n\t\t\t\t20170522131328_DDU366C57","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/A:1006972315739","article-title":"Mechanisms of resistance to pathogenesis in muscular dystrophies","volume":"195","author":"Infante","year":"1999","journal-title":"Mol. Cell. Biochem."},{"key":"key\n\t\t\t\t20170522131328_DDU366C58","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jmb.2007.11.048","article-title":"Myomesin 3, a novel structural component of the M-band in striated muscle","volume":"376","author":"Schoenauer","year":"2008","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C59","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ydbio.2011.10.008","article-title":"Filamin C plays an essential role in the maintenance of the structural integrity of cardiac and skeletal muscles, revealed by the medaka mutant zacro","volume":"361","author":"Fujita","year":"2012","journal-title":"Dev. Biol."},{"key":"key\n\t\t\t\t20170522131328_DDU366C60","first-page":"632","article-title":"Structural and ultrastructural changes in the skeletal muscles of patients in the early stages of Duchenne muscular dystrophy and \"possible\" carriers","volume":"58","author":"Bucciolini Di Sagni","year":"1982","journal-title":"Boll. Soc. Ital. Biol. Sper."},{"key":"key\n\t\t\t\t20170522131328_DDU366C61","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/01.wnl.0000173836.09176.c4","article-title":"Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy","volume":"65","author":"Chen","year":"2005","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170522131328_DDU366C62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0022-510X(90)90256-M","article-title":"Degradation of connectin (titin) in Fukuyama type congenital muscular dystrophy: immunochemical study with monoclonal antibodies","volume":"98","author":"Matsumura","year":"1990","journal-title":"J. Neurol. Sci."},{"key":"key\n\t\t\t\t20170522131328_DDU366C63","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","author":"Rouillon","year":"2014","journal-title":"Neuromuscul. Disord"},{"key":"key\n\t\t\t\t20170522131328_DDU366C64","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00018-012-1248-2","article-title":"Dystrophin deficiency leads to disturbance of LAMP1-vesicle-associated protein secretion","volume":"70","author":"Duguez","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"key\n\t\t\t\t20170522131328_DDU366C65","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/bbrc.1997.7328","article-title":"Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy","volume":"238","author":"Araki","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/23\/24\/6458\/13907404\/ddu366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T00:56:16Z","timestamp":1649638576000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddu366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":65,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2014,7,15]]},"published-print":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddu366","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}